© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
WuXi Biologics (Cayman) Inc. (WXIBF) stock remained unchanged at $6.23 a share on OTC. The stock opened at $6.45, fluctuating between $6.23 to $6.45 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | 6.23 | 6.23 | 6.23 | 6.23 | 830 |
| Aug 26, 2026 | 6.45 | 6.45 | 6.45 | 6.45 | 9.46K |
| Aug 17, 2026 | 6.20 | 6.20 | 6.20 | 6.20 | 2.12K |
| Aug 12, 2026 | 6.00 | 6.00 | 5.85 | 5.85 | 5.34K |
| Aug 04, 2026 | 4.65 | 4.65 | 4.65 | 4.65 | 694 |
| Aug 03, 2026 | 4.60 | 4.60 | 4.60 | 4.60 | 572 |
| Jul 17, 2026 | 4.60 | 4.60 | 4.60 | 4.60 | 4.21K |
| Jul 08, 2026 | 4.75 | 4.75 | 4.60 | 4.60 | 2.08K |
| Jul 06, 2026 | 4.63 | 4.76 | 4.63 | 4.76 | 15.69K |
| Jul 02, 2026 | 4.75 | 4.80 | 4.68 | 4.68 | 4.28K |
| Jun 18, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 1.94K |
| Jun 03, 2026 | 4.40 | 4.40 | 4.40 | 4.40 | 559 |
| May 26, 2026 | 4.18 | 4.18 | 4.18 | 4.18 | 887 |
| May 19, 2026 | 4.18 | 4.18 | 4.18 | 4.18 | 4.28K |
| May 18, 2026 | 4.21 | 4.21 | 4.21 | 4.21 | 385 |
| May 11, 2026 | 4.30 | 4.30 | 4.30 | 4.30 | 1.5K |
| May 07, 2026 | 4.06 | 4.08 | 4.06 | 4.08 | 6.07K |
| May 04, 2026 | 4.05 | 4.05 | 4.05 | 4.05 | 485 |
| Apr 23, 2026 | 4.70 | 4.70 | 4.70 | 4.70 | 4.31K |
| Mar 11, 2026 | 4.60 | 4.60 | 4.60 | 4.60 | 5K |
WuXi Biologics (Cayman) Inc. provides extensive global services, spanning the entire biopharmaceutical process from drug discovery to advanced development and manufacturing, catering to clients in China, North America, Europe, and other international markets. The company also offers expert consultation in biopharmaceutical technology, facilitates international sales contracting, develops and performs advanced testing services, and manages sales and marketing initiatives. Furthermore, it provides clinical and manufacturing support for biologics, manufactures and distributes medical products, serves as a contract development and manufacturing organization (CDMO) for vaccines, and functions as a material supplier. WuXi Biologics maintains significant strategic collaborations with partners such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc. The organization, founded in 2014, is headquartered in Wuxi, China.
| Employees | 13252 |
| Beta | 0.6 |
| Sales or Revenue | $17.03B |
| 5Y Sales Change% | 5.362% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |